{"id":"tg-c","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site pain or swelling"},{"rate":null,"effect":"Joint effusion"},{"rate":null,"effect":"Infection at implant site"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"TG-C uses an ex vivo gene therapy approach where patient or donor chondrocytes are transfected with a TGF-β3 gene, then implanted into the damaged cartilage defect. The TGF-β3 protein secreted by these modified cells stimulates cartilage matrix synthesis and tissue regeneration. This approach aims to restore functional cartilage in joint defects.","oneSentence":"TG-C is a gene therapy that delivers TGF-β3 to cartilage tissue to promote cartilage regeneration and repair.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:38:20.485Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Articular cartilage defects of the knee"}]},"trialDetails":[{"nctId":"NCT06317662","phase":"PHASE2","title":"Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2025-06-05","conditions":"Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia","enrollment":153},{"nctId":"NCT03914625","phase":"PHASE3","title":"A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-07-03","conditions":"B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma, Down Syndrome","enrollment":6720},{"nctId":"NCT06124157","phase":"PHASE3","title":"A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2025-05-30","conditions":"B Acute Lymphoblastic Leukemia","enrollment":222},{"nctId":"NCT03959085","phase":"PHASE3","title":"Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy","status":"RECRUITING","sponsor":"Children's Oncology Group","startDate":"2019-10-31","conditions":"B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma, Central Nervous System Leukemia","enrollment":5951},{"nctId":"NCT03007147","phase":"PHASE3","title":"Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2017-08-08","conditions":"Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia","enrollment":475},{"nctId":"NCT07072585","phase":"PHASE2, PHASE3","title":"Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL)","status":"NOT_YET_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2026-06-28","conditions":"Stage II T Lymphoblastic Leukemia/Lymphoma, Stage III T Lymphoblastic Leukemia/Lymphoma, Stage IV T Lymphoblastic Leukemia/Lymphoma","enrollment":1708},{"nctId":"NCT03203330","phase":"PHASE3","title":"A Study to Determine the Safety and Efficacy of TG-C in Subjects With Kellgren and Lawrence Grade 2 or 3 OA of the Knee","status":"ACTIVE_NOT_RECRUITING","sponsor":"Kolon TissueGene, Inc.","startDate":"2018-10-30","conditions":"Degenerative Osteoarthritis","enrollment":535},{"nctId":"NCT03291470","phase":"PHASE3","title":"Study to Determine the Efficacy and Safety of TG-C in Subjects With Kellgren/Lawrence Grade 2 or 3 OA of the Knee","status":"ACTIVE_NOT_RECRUITING","sponsor":"Kolon TissueGene, Inc.","startDate":"2021-12-09","conditions":"Degenerative Osteoarthritis","enrollment":531},{"nctId":"NCT02168738","phase":"NA","title":"Investigation of Docosahexaenoic Acid (DHA) Metabolic Pathway in Human by Using 13C Labeled Molecules","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2014-03","conditions":"Healthy Subject","enrollment":4},{"nctId":"NCT02101853","phase":"PHASE3","title":"Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2014-12-17","conditions":"Recurrent B Acute Lymphoblastic Leukemia","enrollment":669},{"nctId":"NCT02112916","phase":"PHASE3","title":"Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2014-10-04","conditions":"Adult T Acute Lymphoblastic Leukemia, Ann Arbor Stage II Adult Lymphoblastic Lymphoma, Ann Arbor Stage II Childhood Lymphoblastic Lymphoma","enrollment":847},{"nctId":"NCT02883049","phase":"PHASE3","title":"Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2012-02-29","conditions":"B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, Central Nervous System Leukemia","enrollment":5949},{"nctId":"NCT07164079","phase":"NA","title":"Rubus Sanctus (Wild Blackberry) Root Extract as a Dietary Supplement for Graves' Disease","status":"RECRUITING","sponsor":"Betul Uner","startDate":"2024-12-12","conditions":"Graves Disease (Basedow's Disease)","enrollment":42},{"nctId":"NCT07130188","phase":"","title":"Predictors for ACS and Complexity of CAD","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2025-09-01","conditions":"TG Index, TG/HDL-C Ratio, Young Population","enrollment":130},{"nctId":"NCT07119034","phase":"","title":"Assessment of Oxidative Stress Contents in Jordanian Pregnant Women With Preeclampsia","status":"COMPLETED","sponsor":"Future University in Egypt","startDate":"2022-11-01","conditions":"Preeclampsia (PE), Oxidative Stress","enrollment":90},{"nctId":"NCT02521493","phase":"PHASE3","title":"Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2015-12-23","conditions":"Acute Myeloid Leukemia, Down Syndrome, Myelodysplastic Syndrome","enrollment":280},{"nctId":"NCT07063628","phase":"","title":"Triglyceride-Glucose Indices and Left Ventricular Speckle Tracking in Predicting Coronary Artery Disease Severity","status":"COMPLETED","sponsor":"Damanhour University","startDate":"2025-04-30","conditions":"Coronary Artery Disease","enrollment":508},{"nctId":"NCT04998981","phase":"PHASE3","title":"A Phase 3 Study to Evaluate the Efficacy and Safety of K-877 in Chinese Patients With High TG and Low HDL-C","status":"COMPLETED","sponsor":"Kowa Company, Ltd.","startDate":"2021-09-17","conditions":"Hyperlipidemia","enrollment":353},{"nctId":"NCT05050240","phase":"NA","title":"BATokines as Biomarkers of Brown Fat in Humans","status":"ACTIVE_NOT_RECRUITING","sponsor":"Rockefeller University","startDate":"2021-10-12","conditions":"Healthy Lifestyle","enrollment":20},{"nctId":"NCT06909279","phase":"NA","title":"Caregiver Training to Support Children With Social Communication Challenges","status":"RECRUITING","sponsor":"Western University, Canada","startDate":"2025-05-06","conditions":"Autism Spectrum Disorder, Suspected Autism, Social Communication Challenges","enrollment":72},{"nctId":"NCT00408005","phase":"PHASE3","title":"Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2007-01-30","conditions":"T Acute Lymphoblastic Leukemia, T Lymphoblastic Lymphoma","enrollment":1895},{"nctId":"NCT01190930","phase":"PHASE3","title":"Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2010-08-09","conditions":"Acute Lymphoblastic Leukemia, Adult B Lymphoblastic Lymphoma, Ann Arbor Stage I B Lymphoblastic Lymphoma","enrollment":9350},{"nctId":"NCT02828358","phase":"PHASE2","title":"Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2017-04-01","conditions":"Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia","enrollment":78},{"nctId":"NCT06833918","phase":"","title":"LIPCAR, Cuproptosis, and Α-SMA in the Pathogenesis of AMI and Remodeling","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2025-03","conditions":"Acute Myocardial Infarction (AMI)","enrollment":50},{"nctId":"NCT06144970","phase":"PHASE1","title":"Study to Determine the Safety and Tolerability of TG-C in Subjects with Back Pain Due to Degenerative Disc Disease","status":"NOT_YET_RECRUITING","sponsor":"Kolon TissueGene, Inc.","startDate":"2025-11-01","conditions":"Degenerative Disc Disease","enrollment":24},{"nctId":"NCT05276011","phase":"PHASE2","title":"A Study to Determine the Safety and Efficacy of TG-C in Subjects with Symptomatic Early Hip Osteoarthritis","status":"NOT_YET_RECRUITING","sponsor":"Kolon TissueGene, Inc.","startDate":"2025-10","conditions":"Degenerative Osteoarthritis","enrollment":255},{"nctId":"NCT06690684","phase":"","title":"Identification and Functional Study of Novel Biomarkers for Cardiovascular Diseases","status":"ENROLLING_BY_INVITATION","sponsor":"Ya-Wei Xu","startDate":"2023-10-17","conditions":"Angiocardiography, Heart Failure, Ischemic Heart Disease","enrollment":300},{"nctId":"NCT06463990","phase":"","title":"Influence of TyG Index and TG/HDL-C Ratio on Fetal Macrosomia","status":"COMPLETED","sponsor":"Ankara Etlik City Hospital","startDate":"2023-01-01","conditions":"Fetal Macrosomatia, Lipid Metabolism Disorders, Hyperlipidemias","enrollment":302},{"nctId":"NCT06443723","phase":"NA","title":"Metabolic Dysfunction Associated Fatty Liver Disease in Long-Term Cholecystectomy Patients","status":"COMPLETED","sponsor":"Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital","startDate":"2023-11-01","conditions":"Liver Steatoses","enrollment":149},{"nctId":"NCT06204393","phase":"","title":"To Investigate the Effect of 2019 Novel Coronavirus Infection on the Condition of Patients With Hyperthyroidism","status":"UNKNOWN","sponsor":"Qilu Hospital of Shandong University","startDate":"2023-01-07","conditions":"Graves Disease, COVID-19","enrollment":120},{"nctId":"NCT06210750","phase":"PHASE2","title":"Adding Targeted Drugs to Usual Chemotherapy for Adults With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LBL)","status":"WITHDRAWN","sponsor":"National Cancer Institute (NCI)","startDate":"2024-08-09","conditions":"T Acute Lymphoblastic Leukemia, T Lymphoblastic Lymphoma","enrollment":""},{"nctId":"NCT05331807","phase":"EARLY_PHASE1","title":"Omega-3 and Vitamin D Supplementation in Breast Cancer Women","status":"COMPLETED","sponsor":"Universiti Sains Malaysia","startDate":"2022-04-20","conditions":"Breast Cancer Female","enrollment":88},{"nctId":"NCT06299800","phase":"","title":"Phenotyping Patients With Type 2 Diabetes Mellitus and Cancer","status":"RECRUITING","sponsor":"Azienda Ospedaliero Universitaria Maggiore della Carita","startDate":"2024-02-04","conditions":"Diabetes Mellitus, Type 2, Cancer","enrollment":779},{"nctId":"NCT06151990","phase":"","title":"Assessment of Lipid Profile in Juvenile Systemic Lupus Erythematosus","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2023-12","conditions":"Systemic Lupus Erythematosus","enrollment":102},{"nctId":"NCT05742022","phase":"PHASE2, PHASE3","title":"\"Phospholipovit\" vs Placebo in Patients With Combined Hyperlipidemia","status":"COMPLETED","sponsor":"Institute of Biomedical Chemistry, Russia","startDate":"2016-01-01","conditions":"Combined Hyperlipidemia","enrollment":100},{"nctId":"NCT03198962","phase":"","title":"Use of Amphetamine-type Stimulants & Its Relationship With HIV Incidence and Antiretroviral Adherence Among MSM and TG","status":"COMPLETED","sponsor":"Thai Red Cross AIDS Research Centre","startDate":"2016-11-15","conditions":"HIV Infections","enrollment":510},{"nctId":"NCT00549848","phase":"PHASE3","title":"Total Therapy Study XVI for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia","status":"COMPLETED","sponsor":"St. Jude Children's Research Hospital","startDate":"2007-10-29","conditions":"Acute Lymphoblastic Leukemia","enrollment":600},{"nctId":"NCT01496963","phase":"","title":"Prevalence of Pulmonary Hypertension (PAH) in Patients With Thalassemia","status":"COMPLETED","sponsor":"Ente Ospedaliero Ospedali Galliera","startDate":"2012-01","conditions":"Thalassemia Major, Thalassemia Intermedia, Pulmonary Arterial Hypertension","enrollment":1500},{"nctId":"NCT05226377","phase":"","title":"Relation Between Atherogenic Index of COVID-19 and Upcoming Cardiac Morbidity and Mortality in Non-Cardiac Patients","status":"COMPLETED","sponsor":"Tanta University","startDate":"2021-03-07","conditions":"COVID-19","enrollment":302},{"nctId":"NCT05214872","phase":"","title":"The Impact of Selected Factors on the Cardiovascular System in Chronic Kidney Disease","status":"COMPLETED","sponsor":"Poznan University of Medical Sciences","startDate":"2016-03-25","conditions":"Atherosclerosis of Artery, Inflammation, Chronic Kidney Diseases","enrollment":252},{"nctId":"NCT00369317","phase":"PHASE3","title":"Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2007-03","conditions":"Childhood Acute Basophilic Leukemia, Childhood Acute Eosinophilic Leukemia, Childhood Acute Erythroleukemia (M6)","enrollment":205},{"nctId":"NCT05144672","phase":"","title":"Irisin And Diabetic Nephropathy","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2022-01-01","conditions":"Irisin","enrollment":90},{"nctId":"NCT03663127","phase":"NA","title":"Evaluation of \"Beauty Drink\" on Regulation of Blood Pressure Effect by Clinical Trial","status":"COMPLETED","sponsor":"Chung Shan Medical University","startDate":"2018-07-26","conditions":"Hypertension","enrollment":50},{"nctId":"NCT04946786","phase":"","title":"Clinical, Biochemical and Body Composition Analysis in Assessment of Steatosis in Non Alcoholic Fatty Liver Disease","status":"UNKNOWN","sponsor":"Sohag University","startDate":"2021-07-01","conditions":"Non-alcoholic Fatty Liver Disease NAFLD","enrollment":80},{"nctId":"NCT00103285","phase":"PHASE3","title":"Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2005-04-11","conditions":"Acute Lymphoblastic Leukemia, Childhood B Acute Lymphoblastic Leukemia","enrollment":5377},{"nctId":"NCT03828955","phase":"NA","title":"Evaluation of Soybean Peptides Product on Regulation of Blood Pressure Effect in Humans","status":"COMPLETED","sponsor":"Chung Shan Medical University","startDate":"2016-03","conditions":"Hypertension","enrollment":30},{"nctId":"NCT04159532","phase":"PHASE4","title":"Comparative Study of Three Different Formulations of Omega-3 (EPA+DHA)","status":"COMPLETED","sponsor":"SCF Pharma","startDate":"2019-12-18","conditions":"Healthy Adults","enrollment":36},{"nctId":"NCT00075725","phase":"PHASE3","title":"Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2003-12-29","conditions":"Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia, Childhood B Acute Lymphoblastic Leukemia","enrollment":3154},{"nctId":"NCT00671034","phase":"PHASE3","title":"Calaspargase Pegol or Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2008-07-21","conditions":"Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia, Childhood B Acute Lymphoblastic Leukemia","enrollment":166},{"nctId":"NCT00866307","phase":"PHASE1","title":"Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011)","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2009-02-23","conditions":"Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia, Childhood B Acute Lymphoblastic Leukemia","enrollment":104},{"nctId":"NCT00439296","phase":"PHASE1, PHASE2","title":"ABT-751 With Chemotherapy for Relapsed Pediatric ALL","status":"TERMINATED","sponsor":"Therapeutic Advances in Childhood Leukemia Consortium","startDate":"2006-05-22","conditions":"Recurrent Pediatric ALL, Relapsed Pediatric ALL, Acute Lymphoblastic Leukemia","enrollment":9},{"nctId":"NCT04455204","phase":"","title":"Adipokines, Inflammation, Insulin Resistance and Endothelial Dysfunction in Preeclampsia","status":"COMPLETED","sponsor":"Tanta University","startDate":"2016-04-25","conditions":"Pre-Eclampsia","enrollment":60},{"nctId":"NCT02585869","phase":"PHASE2","title":"Efficacy and Safety of Gemcabene in Patients With Low HDL-C and Either Normal or Elevated Triglycerides","status":"COMPLETED","sponsor":"NeuroBo Pharmaceuticals Inc.","startDate":"1999-12","conditions":"Hypercholesterolemia, Hypertriglyceridemia","enrollment":161},{"nctId":"NCT02719028","phase":"PHASE2","title":"Trial of Antroquinonol in Patients With Hypercholesterolemia and Hyperlipidemia","status":"COMPLETED","sponsor":"Golden Biotechnology Corporation","startDate":"2016-05","conditions":"Hyperlipidemias","enrollment":120},{"nctId":"NCT03654391","phase":"NA","title":"Study of Obesity Control by Astragalus and Notoginseng Extrats","status":"COMPLETED","sponsor":"Chung Shan Medical University","startDate":"2016-10","conditions":"Obesity","enrollment":38},{"nctId":"NCT02537912","phase":"NA","title":"Blood Glucose and Body Fat Regulatory Effect of Peanut Skin Extract","status":"COMPLETED","sponsor":"Chung Shan Medical University","startDate":"2013-12","conditions":"Obesity","enrollment":30},{"nctId":"NCT03750604","phase":"NA","title":"Central Obesity in Cases of OAB","status":"COMPLETED","sponsor":"Mansoura University","startDate":"2017-01-01","conditions":"Urologic Diseases, Overactive Bladder Syndrome, Obesity, Abdominal","enrollment":250},{"nctId":"NCT03482180","phase":"PHASE3","title":"Evaluate the Efficacy and Safety of KI1106 in Patients Whose TG Level is Not Adequately Controlled With Atorvastatin Calcium Monotherapy While LDL-C is Properly Controlled","status":"COMPLETED","sponsor":"Kuhnil Pharmaceutical Co., Ltd.","startDate":"2016-05-04","conditions":"Dyslipidemias","enrollment":215},{"nctId":"NCT00300976","phase":"NA","title":"The Japan Diabetes Optimal Integrated Treatment Study for 3 Major Risk Factors of Cardiovascular Diseases","status":"UNKNOWN","sponsor":"Japan Foundation for the Promotion of International Medical Research Cooperation","startDate":"2006-05","conditions":"Cardiovascular Diseases, Diabetes Mellitus, Type 2","enrollment":2542},{"nctId":"NCT00002744","phase":"PHASE3","title":"Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"1996-05","conditions":"Leukemia","enrollment":1970},{"nctId":"NCT03026933","phase":"PHASE3","title":"Evaluate the Efficacy and Safety of KI1107 in Patients Whose TG Level is Not Adequately Controlled With Rosuvastatin Calcium Monotherapy While LDL-C is Properly Controlled","status":"COMPLETED","sponsor":"Kuhnil Pharmaceutical Co., Ltd.","startDate":"2014-05","conditions":"Dyslipidemias","enrollment":215},{"nctId":"NCT02992093","phase":"","title":"A Metabolomic Study of Polycystic Ovary Syndrome With Insulin Resistance and Its Relationship With TCM Syndrome Types","status":"UNKNOWN","sponsor":"Fujian Maternity and Child Health Hospital","startDate":"2016-12","conditions":"PCOS","enrollment":300},{"nctId":"NCT01221441","phase":"PHASE2","title":"Study of TG-C in Patients With Grade 3 Degenerative Joint Disease of the Knee","status":"COMPLETED","sponsor":"Kolon TissueGene, Inc.","startDate":"2011-05","conditions":"Osteoarthritis, Knee","enrollment":102},{"nctId":"NCT00613457","phase":"PHASE3","title":"Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia","status":"COMPLETED","sponsor":"Associazione Italiana Ematologia Oncologia Pediatrica","startDate":"2000-09","conditions":"Leukemia","enrollment":2039},{"nctId":"NCT00003671","phase":"PHASE2","title":"Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphocytic Leukemia","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"1998-12","conditions":"Leukemia","enrollment":59},{"nctId":"NCT00002590","phase":"PHASE2","title":"Combination Chemotherapy in Treating Children With Lymphoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"1994-07","conditions":"Lymphoma","enrollment":221},{"nctId":"NCT00002812","phase":"PHASE3","title":"Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"1996-09","conditions":"Leukemia","enrollment":2078},{"nctId":"NCT00016302","phase":"NA","title":"Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2001-04","conditions":"T-cell Childhood Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia","enrollment":100},{"nctId":"NCT00002798","phase":"PHASE3","title":"Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"1996-08","conditions":"Childhood Acute Erythroleukemia (M6), Childhood Acute Megakaryocytic Leukemia (M7), Childhood Acute Monoblastic Leukemia (M5a)","enrollment":880}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["TissueGene-C"],"phase":"phase_3","status":"active","brandName":"TG-C","genericName":"TG-C","companyName":"Kolon TissueGene, Inc.","companyId":"kolon-tissuegene-inc","modality":"Biologic","firstApprovalDate":"","aiSummary":"TG-C is a gene therapy that delivers TGF-β3 to cartilage tissue to promote cartilage regeneration and repair. Used for Articular cartilage defects of the knee.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}